1075 West Georgia Street
Suite 1890
Vancouver, BC V6E 3C9
Canada
800-783-6056
https://www.digicann.io
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Nicholas J. Kuzyk M.B.A. | CEO & Director | 205.09k | N/D | 1980 |
Mr. Peter Karroll | Director of Branding & Marketing | N/D | N/D | N/D |
Dr. Zbigniew Adam Szybinski M.Sc. | Vice President of Exploration | 87.83k | N/D | N/D |
Ms. Katrin Eckmans | MD & CEO of Farmako GmbH | N/D | N/D | N/D |
Digicann Ventures Inc., together with its subsidiaries, operates in the cannabis industry. It engages in the production, sale, and distribution of cannabis products. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.
La calificación ISS Governance QuickScore de Digicann Ventures Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.